Inhibition of Th17 differentiation by anti-TNF-alpha therapy in uveitis patients with Behçet's disease (Q41954592)

14 October 2017

Inhibition of Th17 differentiation by anti-TNF-alpha therapy in uveitis patients with Behçet's disease (English)

1 reference

14 October 2017

0 references

0 references

1 reference

Sunao Sugita

1

1 reference

14 October 2017

Yuko Kawazoe

2

1 reference

14 October 2017

Ayano Imai

3

1 reference

14 October 2017

Yukiko Yamada

4

1 reference

14 October 2017

Shintaro Horie

5

1 reference

14 October 2017

Manabu Mochizuki

6

1 reference

14 October 2017

1 May 2012

1 reference

Arthritis Research and Therapy

14 October 2017

1 reference

14 October 2017

14

1 reference

14 October 2017

3

1 reference

14 October 2017

R99

1 reference

Th17 cells in Behçet's disease: a new immunoregulatory axis.

14 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446476

Expression of Th-17 and RORγt mRNA in Behçet's Disease.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446476

Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behçet's disease susceptibility loci

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446476

Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behçet's disease

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446476

Comparison of infliximab versus ciclosporin during the initial 6-month treatment period in Behçet disease

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446476

Major role of gamma delta T cells in the generation of IL-17+ uveitogenic T cells

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446476

FOXP3 and the regulation of Treg/Th17 differentiation

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446476

T-cell suppression by programmed cell death 1 ligand 1 on retinal pigment epithelium during inflammatory conditions

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446476

Involvement of Th17 cells and the effect of anti-IL-6 therapy in autoimmune uveitis

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446476

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446476

The role of soluble TNF receptors for TNF-alpha in uveitis

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446476

TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446476

Anti-TNF-alpha therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-beta

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446476

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446476

TNF downmodulates the function of human CD4+CD25hi T-regulatory cells

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446476

TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446476

RORgamma t, a novel isoform of an orphan receptor, negatively regulates Fas ligand expression and IL-2 production in T cells

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446476

Genomic structure and chromosomal mapping of the nuclear orphan receptor ROR gamma (RORC) gene

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446476

Enhanced production of in vitro tumor necrosis factor-alpha from monocytes in Behçet's disease

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446476

RORC and Foxp3 axis in cerebrospinal fluid of patients with neuro-Behçet's disease

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446476

Relationship between serum infliximab levels and acute uveitis attacks in patients with Behcet disease

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446476

Suppression of experimental autoimmune uveoretinitis by Anti-IL-17 antibody

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446476

Infliximab effects compared to conventional therapy in the management of retinal vasculitis in Behçet disease

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446476

Upregulated IL-23 and IL-17 in Behçet patients with active uveitis.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446476

Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet's disease: an open-label trial

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446476

Risk and prognostic factors of poor visual outcome in Behcet's disease with ocular involvement

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446476

Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behçet's disease with refractory uveoretinitis

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446476

Effect of infliximab on sight-threatening panuveitis in Behçet's disease.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446476

Oral tolerance in a murine model of relapsing experimental autoimmune uveoretinitis (EAU): induction of protective tolerance in primed animals

18 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2FAR3824

Identification of a new epitope of human IRBP that induces autoimmune uveoretinitis in mice of the H-2b haplotype

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446476

Anti-tumor necrosis factor alpha therapy suppresses the induction of experimental autoimmune uveoretinitis in mice by inhibiting antigen priming

3 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446476

A new model of autoimmune disease. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens

3 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446476

Effect of infliximab on threatening panuveitis in Behçet's disease

3 November 2018

1 reference

12 December 2020

Cytokine profile in Behçet's disease patients. Relationship with disease activity

1 reference

12 December 2020

Divergent cytokine production profile in Behçet's disease. Altered Th1/Th2 cell cytokine pattern

1 reference

12 December 2020

Cytokine production by T cells infiltrating in the eye of uveitis patients

1 reference

12 December 2020

IL-23 promotes CD4+ T cells to produce IL-17 in Vogt-Koyanagi-Harada disease

1 reference

12 December 2020

Differential roles for IFN- and IL-17 in experimental autoimmune uveoretinitis

1 reference

12 December 2020

Immune responses to interphotoreceptor retinoid-binding protein and S-antigen in Behcet's patients with uveitis

1 reference

12 December 2020

Timing of recurrent uveitis in patients with Behcet's disease receiving infliximab treatment

1 reference

12 December 2020

Induction of regulatory T cells by infliximab in Behcet's disease

1 reference

12 December 2020

Identifiers

DOI

10.1186/AR3824

1 reference

14 October 2017

1 reference

14 October 2017

PubMed publication ID

22546542

1 reference